A detailed history of Hantz Financial Services, Inc. transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Hantz Financial Services, Inc. holds 21 shares of MRVI stock, worth $101. This represents 0.0% of its overall portfolio holdings.

Number of Shares
21
Previous 21 -0.0%
Holding current value
$101
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024

BUY
$6.87 - $11.34 $144 - $238
21 New
21 $0
Q1 2024

Aug 06, 2024

SELL
$5.11 - $8.76 $97 - $166
-19 Reduced 13.48%
122 $1,000
Q4 2023

Aug 06, 2024

SELL
$4.7 - $9.87 $48,677 - $102,223
-10,357 Reduced 98.66%
141 $1,000
Q3 2023

Aug 06, 2024

BUY
$9.14 - $12.85 $6,928 - $9,740
758 Added 7.78%
10,498 $105,000
Q2 2023

Aug 06, 2024

BUY
$12.09 - $15.0 $894 - $1,110
74 Added 0.77%
9,740 $121,000
Q1 2023

Aug 06, 2024

BUY
$12.99 - $16.48 $18,160 - $23,039
1,398 Added 16.91%
9,666 $135,000
Q4 2022

Aug 06, 2024

BUY
$12.5 - $24.78 $5,400 - $10,704
432 Added 5.51%
8,268 $118,000
Q3 2022

Aug 06, 2024

BUY
$20.6 - $30.37 $12,133 - $17,887
589 Added 8.13%
7,836 $200,000
Q2 2022

Aug 06, 2024

BUY
$26.05 - $37.48 $20,709 - $29,796
795 Added 12.32%
7,247 $206,000
Q1 2022

Aug 06, 2024

BUY
$24.46 - $40.92 $32,776 - $54,832
1,340 Added 26.21%
6,452 $228,000
Q4 2021

Aug 06, 2024

BUY
$35.0 - $45.94 $34,440 - $45,204
984 Added 23.84%
5,112 $214,000
Q3 2021

Aug 06, 2024

BUY
$36.8 - $60.62 $31,979 - $52,678
869 Added 26.66%
4,128 $203,000
Q2 2021

Aug 06, 2024

BUY
$32.46 - $45.0 $49,826 - $69,075
1,535 Added 89.04%
3,259 $136,000
Q1 2021

Aug 06, 2024

BUY
$25.8 - $38.49 $43,937 - $65,548
1,703 Added 8109.52%
1,724 $61,000
Q4 2020

Aug 06, 2024

BUY
$24.5 - $30.86 $26,141 - $32,927
1,067 Added 5080.95%
1,088 $31,000

Others Institutions Holding MRVI

About MARAVAI LIFESCIENCES HOLDINGS, INC.


  • Ticker MRVI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 131,540,000
  • Market Cap $638M
  • Description
  • Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...
More about MRVI
Track This Portfolio

Track Hantz Financial Services, Inc. Portfolio

Follow Hantz Financial Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hantz Financial Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hantz Financial Services, Inc. with notifications on news.